Table of Content


Introduction
Pheochromocytoma - Overview
Pheochromocytoma - Therapeutics Development
Pheochromocytoma - Therapeutics Assessment
Pheochromocytoma - Companies Involved in Therapeutics Development
Pheochromocytoma - Drug Profiles
Pheochromocytoma - Dormant Projects
Pheochromocytoma - Discontinued Products
Pheochromocytoma - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Pheochromocytoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Pheochromocytoma, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Pheochromocytoma - Pipeline by Advanced Accelerator Applications SA, H2 2020
Pheochromocytoma - Pipeline by AstraZeneca Plc, H2 2020
Pheochromocytoma - Pipeline by Enterome Bioscience SA, H2 2020
Pheochromocytoma - Pipeline by Exelixis Inc, H2 2020
Pheochromocytoma - Pipeline by Fujifilm Holdings Corp, H2 2020
Pheochromocytoma - Pipeline by Gibson Oncology LLC, H2 2020
Pheochromocytoma - Pipeline by Ipsen SA, H2 2020
Pheochromocytoma - Pipeline by Jubilant DraxImage Inc, H2 2020
Pheochromocytoma - Pipeline by Lixte Biotechnology Holdings Inc, H2 2020
Pheochromocytoma - Pipeline by Oncoceutics Inc, H2 2020
Pheochromocytoma - Pipeline by Pfizer Inc, H2 2020
Pheochromocytoma - Pipeline by Tarveda Therapeutics Inc, H2 2020
Pheochromocytoma - Pipeline by Vyriad Inc, H2 2020
Pheochromocytoma - Dormant Projects, H2 2020